Drostanolone

The synthesis of the DHT derivative Drostanolone Propionate was first described in 1959. It was not until the late 1960s that Drolban, a Drostanolone Propionate product for the treatment of breast cancer in women, was launched onto the market. The active ingredient is also known under the brand name Masteron, or user names such as Drost or Drosta. Drostanolone is available as a short-term and long-term ester (enanthate)

In bodybuilding, Masteron is used by athletes who want to gain muscle hardness. Because it docks to the aldosterone receptor and helps to drain, it is usually used 4-8 weeks before a competition to prepare for the competition. Drosta helps improve training performance and recovery time during a bodybuilding session. Usually it is stacked with other steroids, e.g. with various testosterones like trenbolone or stanozolol.

Side effects:

Hair loss, acne, oily skin, high blood pressure, negative changes in blood lipid levels, prostate enlargement, lower voice, increased aggressiveness, sleep disorders. When used for extended periods of time, the central nervous system can be damaged.

Application / Dosage:

Common dosages in bodybuilding of drost are between 30 – 100 mg / day.
Drostanolone Enanthate is often used between 250 – 750 mg / week.
A Ciclus lasts on average between 4 and 8 weeks.